Fabrice Andre

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Fabrice Andre
Dec 13, 2024, 05:49 | Insight
Highlights from Day 3 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Dec 11, 2024, 09:53 | Insight
Thomas Powles was appointed Editor-in-Chief of Annals of Oncology
Thomas Powles was appointed  the Editor-in-Chief of Annals of Oncology in early 2024. Thomas Powles,…
Dec 7, 2024, 10:48 | Insight
Use of the ESMO-Magnitude of Clinical Benefit Scale for HTA Recommendations
Fabrice Andre shared a post on X: "One key mission of ESMO is to deliver Frameworks…
Nov 2, 2024, 12:01 | Positive
Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…
Oct 6, 2024, 13:51 | Blog
The integration of cancer biomarkers allowing remarkable advancements in cancer therapeutics
Jean-Charles Soria shared a post on Linkedin: '' The integration of cancer biomarkers has revolutionized…
Aug 31, 2024, 16:51 | Insight
Vivek Subbiah: Future framework for Tissue agnostic drug development
Vivek Subbiah shared a post on LinkedIn: "Hot off the press, Presenting to the world a…
Aug 29, 2024, 16:04 | Societies
Creating a favourable framework for tissue-agnostic research - ESMO
ESMO shared on LinkedIn: "Advances in Precision Oncology are reshaping Cancer Care, moving towards a…
Aug 20, 2024, 10:02 | Blog
Toni Choueiri: Announcement for folks going to ESMO24
Toni Choueiri shared a post on X by Daniel Castellano, Medical Oncologist at University Hospital…
Aug 6, 2024, 02:02 | Insight
Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Jun 12, 2024, 04:23 | Insight
Piotr Wysocki: Physicial exercise reduces the risk of recurrence - TNBC and HER2+/HR- breast cancer
Piotr Wysocki recently posted on LinkedIn: "Soldato D et al. conducted a multicenter prospective cohort analysis…
Jun 9, 2024, 08:43 | Insight
Daniel Stover: Activity post-breast cancer diagnosis: Is ‘exercise’ just ‘exercise’?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jun 2, 2024, 23:39 | Blog
Hope Rugo: Fabrice Andre presents DB07 at ASCO24
Hope Rugo, Medical hematologist-oncologist at UCSF, shared on X/Twitter: "Fabrice Andre presents DB07. The expected amazing…
May 23, 2024, 14:29 | Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
May 19, 2024, 02:10 | Societies
Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making 
Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: . "At…
May 14, 2024, 16:52 | Insight
Fabrice Andre: This risk-based approach is the foundation of modern cancer prevention centers
Fabrice Andre, Head of Research Division at Gustave Roussy, shared on X: "In this review ⁦of…
May 2, 2024, 14:25 | Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
Apr 30, 2024, 14:56 | Blog
Fabrice Andre: ESMO is launching a monthly virtual journal club
Fabrice Andre, Head of Research Division at Gustave Roussy and President-Elect at ESMO, shared on…
Apr 29, 2024, 10:43 | Blog
Stephanie Graff: Getting excited for ASCO24. Abstract titles are officially out
Stephanie Graff shared a post on X: "Getting excited for ASCO24 Annual Meeting. Abstract titles are…
Apr 14, 2024, 07:20 | Societies
Daniel Castellano: The ASCO24 football tournament is back again this year
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X/Twitter: ''The most funky,…
Feb 11, 2024, 12:19 | Blog
Benedikt Westphalen: I'm deeply grateful for the opportunity to chair the ESMO Translational Research and Precision Medicine Working
Benedikt Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, recently posted…
Jan 29, 2024, 14:13 | History
Fabrice Andre: Academic clinical trials should be evaluated mainly based on their IMPACT on patients, not only on innovation
Fabrice Andre, Head of Research Division of Gustave Roussy, President Elect of the European Society…
Dec 9, 2023, 17:01 | Blog
Fabrice Andre: Aside trials testing Innovations, there is a need for trials testing pragmatic questions in oncology
Fabrice Andre, Head of Research Division at Gustave Roussy Institute, recently shared on X/Twitter: “Aside trials testing Innovations,…
Oct 21, 2023, 19:09 | Societies
Evandro de Azambuja: We are over 34,000 members at ESMO
Evandro de Azambuja, ESMO Director of Membership 2023-2024, shared on his Twitter: "As the ESMO…
Oct 1, 2023, 00:34 | Positive
Vivek Subbiah: Can oncologists kick a football? Of course they kick cancer every day.
Oncologists are excited about an upcoming football event. "Finally 'Habemus football' after successful last SOCCER-ASCO#23…
Jul 27, 2023, 07:14 | Blog
DAISY Such a key publication in our growing understanding of T-DXd - Stephanie Graff
DAISY Such a key publication in our growing understanding of T-DXd, particularly across the spectrum…
All: 25 Posts: 1 - 100
Special Coverage